A detailed history of American Century Companies Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, American Century Companies Inc holds 328,957 shares of CYTK stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
328,957
Previous 331,444 0.75%
Holding current value
$15.4 Million
Previous $18 Million 3.28%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$51.22 - $60.16 $127,384 - $149,617
-2,487 Reduced 0.75%
328,957 $17.4 Million
Q2 2024

Aug 07, 2024

SELL
$47.86 - $75.05 $4.04 Million - $6.33 Million
-84,410 Reduced 20.3%
331,444 $18 Million
Q1 2024

May 14, 2024

SELL
$63.75 - $108.06 $35.1 Million - $59.6 Million
-551,146 Reduced 57.0%
415,854 $29.2 Million
Q4 2023

Feb 13, 2024

BUY
$26.88 - $83.49 $26 Million - $80.7 Million
967,000 New
967,000 $80.7 Million
Q3 2023

Nov 13, 2023

SELL
$29.46 - $36.61 $14.7 Million - $18.3 Million
-499,060 Reduced 18.32%
2,225,762 $65.6 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $1.5 Million - $1.88 Million
46,124 Added 1.72%
2,724,822 $88.9 Million
Q1 2023

May 11, 2023

BUY
$33.36 - $45.71 $49.9 Million - $68.4 Million
1,496,881 Added 126.66%
2,678,698 $94.3 Million
Q4 2022

Feb 13, 2023

BUY
$35.77 - $51.11 $25.7 Million - $36.7 Million
718,472 Added 155.06%
1,181,817 $54.2 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $894,243 - $1.27 Million
23,203 Added 5.27%
463,345 $22.4 Million
Q2 2022

Aug 12, 2022

BUY
$33.93 - $48.92 $1.02 Million - $1.47 Million
29,989 Added 7.31%
440,142 $17.3 Million
Q1 2022

May 11, 2022

SELL
$29.74 - $46.0 $188,670 - $291,824
-6,344 Reduced 1.52%
410,153 $15.1 Million
Q4 2021

Feb 07, 2022

BUY
$34.35 - $46.38 $2.32 Million - $3.13 Million
67,504 Added 19.34%
416,497 $19 Million
Q3 2021

Nov 10, 2021

BUY
$18.54 - $35.74 $6.47 Million - $12.5 Million
348,993 New
348,993 $12.5 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.4B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.